 computed tomography of ct angiography (cta) with and without enhancement show:
    ill martginated tumor over s4 liver    
    isolated dilatation of bilateral ihds with s/p biliary stent
    no definite enlargement of retroperitoneal lns  .
    no definite obstructive uropathy  .
    no abnormal fluid collection in the abdomen  .
    patency of the portal vein and hepatic artery
    the vol of the right liver is 787cm3 and the left liver is 555cm3
    imp: hilar cholangiocarcinoma with isolated dilatation of the bil ihds
    
    
    ¡´imaging report form for perihilar bile ducts tumor (ajcc 7th edition)
    
    1.tumor number/location: 
        location:  ¡¼ 
    2.tumor size: 
       ¡³measurable:  cm (the largest tumor)
       ¡³non-measurable
    3.pathology: ¡³not available ¡³available (pathology type:¡¼)
    
    -------------------primary tumor(t)--------------------------
     tx    ¡³primary tumor cannot be assessed
     t0    ¡³no primary tumor
    stage 0
     tis   ¡³carcinoma in situ
    stage i
     t1    ¡³tumor confined to the bile duct, with extension up to the muscle 
  layer 
    or fibrous tissue
    stage ii
     t2a   ¡³tumor invades beyond the wall of the bile duct to surrounding
   adipose
     tissue
     t2b   ¡´tumor invades adjacent hepatic parenchyma
    stage iiia
     t3    ¡³tumor invades unilateral branches of the portal vein or hepatic
   artery
    stage iva (t4 n0-n1)
     t4    ¡³tumor invades main portal vein or its branches bilaterally; or the 
    common hepatic artery; or the second-order biliary radicals bilaterally; or
     unilateral
    second-order biliary radicals with contralateral portal vein or hepatic artery
     involvement
    -------------------regional lymph nodes(n)-----------------
     nx    ¡³regional lymph nodes cannot be assessed
     n0    ¡´no regional lymph nodes ¡¼
    stage iiib (t1-3 n1 m0)
     n1    ¡³regional lymph node metastasis (including nodes along the cystic 
  duct,
    common bile duct, hepatic artery, and portal vein)
    stage ivb
     n2    ¡³metastasis to periaortic, pericaval, superior mesentery artery, and/
  or 
    celiac artery lymph nodes
     
    -------------------distant metastasis(m)---------------------
     m0   ¡³no distant metastasis (no pathologic m0; use clinical m to complete 
    stage group)brief hx: hcc post op and recurrence s/p tae f/u
this study has been compared to the previous study on 2017.04.12
ct of the liver with pre-contrast & triphasic contrast enhancement studies show:
 
techniques: 
from lower chest to liver inferior edge in 5-mm contiguous section, contrast 
medium injected at 2ml/sec, 30 sec after initiation of injection, starting 
arterial phase scan; portal phase scan performed in 20 sec after the end of the 
arterial phase scan; and venous phase scan began in 20 sec after the end of 
portal phase scan
findings:
no definite pulmonary nodule in the visualized lower lung field
s/p left lateral segmental hepatectomy 
s/p tae and rfa with dense lipiodol stasis and tissue necrosis in s7
no other early enhance and early washout tumor in the liver
no definite space occupying lesion in the spleen and pancreas.
no definite biliary dilatation but with multiple gallstones noted
patency of portal veins  
no hydronephrosis but left renal stones noted
no definite enlargement of retroperitoneal lns 
no abnormal fluid collection in the abdomen
bil. tiny renal caliceal stones noted
progressive lobulated enlargement of the prostate with bladder base indentation 
r/o prostate tumor or hypertrophy
imp:
s/p lls hepatectomy
s/p tae and rfa with lipiodol stasis and necrotic change in s7
no evident recurrent liver tumor
multiple gallstones and left renal stones
progressive lobulated prostate enlargement r/o prostate tumor or hypertrophy

¡´imaging report form for prostate cancer (ajcc 8th edition)
1. tumor location: ¡³rt¡³ lt ¡³ peripheral ¡³ transitional ¡³ central zone
¡³not assessable
2. tumor size: 
¡³measurable: cm 
¡³non-measurable
3. pathology: ¡´not available ¡³available (histopathologic grade: g¡¼)
4. study method: ¡´ ct scans  ¡³ mri
-------------------primary tumor(t)---------------------------
tx   ¡´primary tumor cannot be assessed 
t0   ¡³no evidence of primary tumor 
t1   ¡³clinically inapparent tumor that is not palpable
t1a  ¡³tumor incidental histologic finding in 5% or less of tissue resected
t1b  ¡³tumor histologic finding in more than 5% of tissue resected
t1c  ¡³tumor identified by needle biopsy in one or both sides
t2   ¡³tumor is palpable and confined within prostate
       t2a  ¡³tumor involves one-half of one side or less
       t2b  ¡³tumor involves more than one-half of one side but not both sides
       t2c  ¡³tumor involves both sides
t3   ¡³extraprostatic tumor is not fixed or does not invade adjacent structure
       t3a  ¡³extraprostatic extension (uni - or bilateral)
       t3b  ¡³tumor invades seminal vesicle(s)
(t2 and t3 only for mri study)
t4   ¡³tumor is fixed or invades adjacent structures other than seminal 
vesicles.
¡³pelvic side wall
¡³pelvic organs invasion 
(if yes, ¡³bladder ¡³rectum ¡³external sphincter¡³levator muscles¡³pelvic wall)
-------------------regional lymph nodes(n)-----------------
nx   ¡³regional lns were not assessed
n0   ¡´no positive regional lns
n1   ¡³metastasis in regional ln(s).
¡³obturator (rt/lt) ¡³internal iliac (rt/lt) ¡³external iliac (rt/lt) ¡³
sacral ¡³others
-------------------distant metastasis(m)-----------------------
m0¡³no distant metastasis
m1   ¡³distant metastasis
    m1a  ¡³nonregional ln(s)
¡³common iliac (rt/lt) ¡³inguinal (rt/lt) ¡³paraaortic (rt/lt) ¡³others
    m1b  ¡³bone(s)
    m1c  ¡³other site(s) with or without bone disease

imaging stage   tx n0( in this study)

    stage ivb
     m1   ¡³distant metastasis¡¼
    
    imaging stage   t2b n0( in this study)
    